Literature DB >> 33374121

Carbapenem-Resistant Pseudomonas aeruginosa Strains-Distribution of the Essential Enzymatic Virulence Factors Genes.

Tomasz Bogiel1, Małgorzata Prażyńska1, Joanna Kwiecińska-Piróg1, Agnieszka Mikucka1, Eugenia Gospodarek-Komkowska1.   

Abstract

Pseudomonas aeruginosa is one of the most commonly isolated bacteria from clinical specimens, with increasing isolation frequency in nosocomial infections. Herein, we investigated whether antimicrobial-resistant P. aeruginosa strains, e.g., metallo-beta-lactamase (MBL)-producing isolates, may possess a reduced number of virulence genes, resulting from appropriate genome management to adapt to a changing hospital environment. Hospital conditions, such as selective pressure, may lead to the replacement of virulence genes by antimicrobial resistance genes that are crucial to survive under current conditions. The study aimed to compare, using PCR, the frequency of the chosen enzymatic virulence factor genes (alkaline protease-aprA, elastase B-lasB, neuraminidases-nan1 and nan2, and both variants of phospholipase C-plcH and plcN) to MBL distribution among 107 non-duplicated carbapenem-resistant P. aeruginosa isolates. The gene encoding alkaline protease was noted with the highest frequency (100%), while the neuraminidase-1 gene was observed in 37.4% of the examined strains. The difference in lasB and nan1 prevalence amongst the MBL-positive and MBL-negative strains, was statistically significant. Although P. aeruginosa virulence is generally more likely determined by the complex regulation of the virulence gene expression, herein, we found differences in the prevalence of various virulence genes in MBL-producers.

Entities:  

Keywords:  Pseudomonas aeruginosa; Pseudomonas aeruginosa genotypes; Pseudomonas aeruginosa virulence; carbapenem-resistant Pseudomonas aeruginosa; carbapenems; resistance to carbapenems; virulence; virulence factor genes

Year:  2020        PMID: 33374121      PMCID: PMC7823804          DOI: 10.3390/antibiotics10010008

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  42 in total

1.  Antibiotic resistance and virulence properties of Pseudomonas aeruginosa strains from mechanically ventilated patients with pneumonia in intensive care units: comparison with imipenem-resistant extra-respiratory tract isolates from uninfected patients.

Authors:  Patrick Di Martino; Hélène Gagnière; Hugues Berry; Laurent Bret
Journal:  Microbes Infect       Date:  2002-05       Impact factor: 2.700

Review 2.  Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies.

Authors:  Zheng Pang; Renee Raudonis; Bernard R Glick; Tong-Jun Lin; Zhenyu Cheng
Journal:  Biotechnol Adv       Date:  2018-11-27       Impact factor: 14.227

3.  Bulgarian cystic fibrosis Pseudomonas aeruginosa isolates: antimicrobial susceptibility and neuraminidase-encoding gene distribution.

Authors:  Tanya Strateva; Guergana Petrova; Penka Perenovska; Ivan Mitov
Journal:  J Med Microbiol       Date:  2009-05       Impact factor: 2.472

4.  Genomic and phenotypic comparison of environmental and patient-derived isolates of Pseudomonas aeruginosa suggest that antimicrobial resistance is rare within the environment.

Authors:  Kay A Ramsay; Samuel J T Wardell; Wayne M Patrick; Ben Brockway; David W Reid; Craig Winstanley; Scott C Bell; Iain L Lamont
Journal:  J Med Microbiol       Date:  2019-11       Impact factor: 2.472

5.  Alkaline protease contributes to pyocyanin production in Pseudomonas aeruginosa.

Authors:  Kazuhiro Iiyama; Eigo Takahashi; Jae Man Lee; Hiroaki Mon; Mai Morishita; Takahiro Kusakabe; Chisa Yasunaga-Aoki
Journal:  FEMS Microbiol Lett       Date:  2017-04-01       Impact factor: 2.742

6.  Molecular detection of virulence genes in Pseudomonas aeruginosa isolated from children with Cystic Fibrosis and burn wounds in Iran.

Authors:  Fatemeh Faraji; Mohammadreza Mahzounieh; Azizollah Ebrahimi; Fatemeh Fallah; Omid Teymournejad; Behnaz Lajevardi
Journal:  Microb Pathog       Date:  2016-07-25       Impact factor: 3.738

7.  Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp.

Authors:  Dongeun Yong; Kyungwon Lee; Jong Hwa Yum; Hee Bong Shin; Gian Maria Rossolini; Yunsop Chong
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

8.  Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp.

Authors:  K Lee; Y S Lim; D Yong; J H Yum; Y Chong
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

9.  Antimicrobial susceptibility and virulence genes of clinical and environmental isolates of Pseudomonas aeruginosa.

Authors:  Siew Mun Liew; Ganeswrei Rajasekaram; Sd Ampalam Puthucheary; Kek Heng Chua
Journal:  PeerJ       Date:  2019-01-22       Impact factor: 2.984

10.  Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins.

Authors:  Philippe Lanotte; Stephane Watt; Laurent Mereghetti; Nathalie Dartiguelongue; Aziz Rastegar-Lari; Alain Goudeau; Roland Quentin
Journal:  J Med Microbiol       Date:  2004-01       Impact factor: 3.196

View more
  5 in total

1.  Targeting the Pseudomonas aeruginosa Virulence Factor Phospholipase C With Engineered Liposomes.

Authors:  Heidi Wolfmeier; Samuel J T Wardell; Leo T Liu; Reza Falsafi; Annette Draeger; Eduard B Babiychuk; Daniel Pletzer; Robert E W Hancock
Journal:  Front Microbiol       Date:  2022-03-18       Impact factor: 5.640

2.  Bacteriophage as a potential therapy to control antibiotic-resistant Pseudomonas aeruginosa infection through topical application onto a full-thickness wound in a rat model.

Authors:  Nouran Rezk; Abdallah S Abdelsattar; Doaa Elzoghby; Mona M Agwa; Mohamed Abdelmoteleb; Rania G Aly; Mohamed S Fayez; Kareem Essam; Bishoy M Zaki; Ayman El-Shibiny
Journal:  J Genet Eng Biotechnol       Date:  2022-09-12

3.  Decoding Genetic Features and Antimicrobial Susceptibility of Pseudomonas aeruginosa Strains Isolated from Bloodstream Infections.

Authors:  Tomasz Bogiel; Dagmara Depka; Mateusz Rzepka; Agnieszka Mikucka
Journal:  Int J Mol Sci       Date:  2022-08-16       Impact factor: 6.208

4.  Epidemiology, Molecular Characteristics, and Virulence Factors of Carbapenem-Resistant Pseudomonas aeruginosa Isolated from Patients with Urinary Tract Infections.

Authors:  Yumi Park; Sun Hoe Koo
Journal:  Infect Drug Resist       Date:  2022-01-14       Impact factor: 4.003

5.  Evaluation of Multidrug-Resistant P. aeruginosa in Healthcare Facility Water Systems.

Authors:  Maria Luisa Cristina; Marina Sartini; Elisa Schinca; Gianluca Ottria; Beatrice Casini; Anna Maria Spagnolo
Journal:  Antibiotics (Basel)       Date:  2021-12-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.